246960 — InnoTherapy Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩59bn
- KR₩58bn
- KR₩1bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3,989 | -3,036 | -5,040 | -5,972 | -5,026 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 221 | -454 | 729 | 1,476 | 1,217 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 81.5 | 76 | -346 | -365 | 189 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3,264 | -2,872 | -3,983 | -4,105 | -2,819 |
Capital Expenditures | -294 | -1,820 | -6,343 | -890 | -2,899 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -573 | -2,437 | -8,167 | 5,928 | 4,431 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -867 | -4,257 | -14,510 | 5,037 | 1,532 |
Financing Cash Flow Items | — | — | 18 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 9,632 | 1,857 | 18,945 | -140 | 4,510 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 5,497 | -5,277 | 455 | 791 | 3,224 |